Ropinirole prolonged release

DRUG2 trials

Sponsors

GlaxoSmithKline, Seoul National University Hospital

Conditions

Parkinson Disease

Phase 3

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

CompletedNCT00331149

GlaxoSmithKlineParkinson Disease

Start: 2006-06-20End: 2007-08-29Updated: 2017-08-22

Phase 4

Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily

CompletedNCT00986245

Seoul National University HospitalParkinson Disease

Start: 2009-09-30End: 2010-12-31Updated: 2013-09-09